glp-1 news nov 2025 Alarming rise in weight loss drug overdoses GLP-1 Weight-Loss Drug Demonstration Begins

Her passion to develop such an obesity drug was reinforced by the fact that one of her immediate family members with the condition suffered a stroke (Mller, Preker

What matters most during this phase is establishing the habits that will determine your long-term results

This has enormous implications for arthritis and autoimmune diseases

Studies have noted higher rates of gastrointestinal disorders, hypotension, syncope, kidney stones (nephrolithiasis), interstitial nephritis, and drug-induced pancreatitis

But as we get older, two things happen: We make less NAD+: Our body's machinery gets rusty

The three FDA-approved injection sites Every GLP-1 receptor agonist currently approved for weight loss uses the same three injection sites